Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Alana on +44 1494 818 020 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Alana McKenna
Principal Account Manager
+44 1494 818 020

Even though I never actually met anyone from Zenopa, all of the support they gave me over the phone or by email which was all I needed to help me on my way.
Claire, 2014

GlaxoSmithKline outlines clinical trial data transparency plans

8 May 2013 11:05 in Pharmaceutical Company Product News

GlaxoSmithKline has provided an update on its broad-ranging plans to share detailed clinical trial data, as part of efforts to improve its operational transparency.

A new online system is being launched that will enable researchers to request access to patient-level data from GlaxoSmithKline clinical trials, thus helping to support scientific understanding and improve patient care.

External independent experts are being appointed to make up a panel that will review research proposals for access to anonymised patient-level data, while a password system will be used to ensure that information can only be accessed for scientific reasons.

It is hoped that this will form the basis of a broader system offering data from clinical trials conducted by multiple organisations, operated by an independent third party.

Patrick Vallance, GlaxoSmithKline's president of pharmaceutical research and development, said: "We are absolutely committed to sharing data so that researchers can examine the details more closely, do their own analyses and learn more about medicines and how they can best be used."

This comes after the firm announced its support for the AllTrials clinical data transparency initiative earlier this year.ADNFCR-8000103-ID-801582334-ADNFCR

Other news stories from 08/05/2013

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd